Kenneth J. Zuerblis

Member of the Board of Directors of Resverlogix Corp., Zenith Capital Corp. and Stemline Iherapeutics Prior positions include: Executive Vice President and Chief Financial Officer of Savient Pharmaceuticals Inc.; Chief Financial Officer and Senior Vice President at ImClone Systems; Chief Financial Officer of Enzon Pharmaceuticals Inc., Corporate Controller; Management at KPMG, LLP Bachelor of Science in Accounting, Seton Hall University Certified public accountant in the State of New Jersey.